Table 3 Results of multilevel models by history of specific comorbidities
From: Impact of statins and ACE inhibitors on mortality after COPD exacerbations
History of comorbid condition | ||
|---|---|---|
Yes | No | |
Myocardial infarction | ||
ACE inhibitor | 0.60 (0.43–0.85) | 0.63 (0.54–0.74) |
Statin | 0.39 (0.27–0.58) | 0.53 (0.44–0.65) |
Congestive heart failure | ||
ACE inhibitor | 0.61 (0.51–0.74) | 0.59 (0.47–0.73) |
Statin | 0.63 (0.51–0.80) | 0.37 (0.29–0.49) |
Stroke | ||
ACE inhibitor | 0.75 (0.54–1.05) | 0.61 (0.52–0.71) |
Statin | 0.41 (0.27–0.63) | 0.54 (0.44–0.65) |
Diabetes | ||
ACE inhibitor | 0.62 (0.47–0.80) | 0.66 (0.56–0.78) |
Statin | 0.49 (0.36–0.67) | 0.54 (0.44–0.66) |